Anthracenedione activation by nadph-cytochrome p-450 reductase; Comparison with anthracyclines
- 15 October 1981
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 30 (20), 2881-2884
- https://doi.org/10.1016/0006-2952(81)90433-0
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drugCancer Chemotherapy and Pharmacology, 1980
- Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen MetabolitesJournal of Clinical Investigation, 1980
- Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenedionesJournal of Medicinal Chemistry, 1979
- Properties of NADPH-cytochrome P-450 reductase purified from rabbit liver microsomesArchives of Biochemistry and Biophysics, 1979
- Comparison of Antineoplastic Activity of Aminoethylaminoanthraquinones and Anthracycline AntibioticsJournal of Pharmaceutical Sciences, 1979
- Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinonesJournal of Medicinal Chemistry, 1978
- Adriamycin stimulated superoxide formation in submitochondrial particlesChemico-Biological Interactions, 1977
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycinBiochemical and Biophysical Research Communications, 1977
- The use of acetylated ferricytochrome C for the detection of superoxide radicals produced in biological membranesBiochemical and Biophysical Research Communications, 1975